openPR Logo
Press release

Pharmacogenomics - Top Companies Regional and Data Analysis

01-21-2025 03:05 PM CET | Health & Medicine

Press release from: The Insight Partners

Pharmacogenomics Market

Pharmacogenomics Market

Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.

Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129

Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmacogenomics - Top Companies Regional and Data Analysis here

News-ID: 3825669 • Views:

More Releases from The Insight Partners

A Complete Guide to Wireless Testing Industry [PDF E-Book]
A Complete Guide to Wireless Testing Industry [PDF E-Book]
Wireless testing service providers are essential players in the ecosystem of the wireless testing market. They ensure that devices and networks must be within the stated performance, interoperability, and security standards. In the wireless testing market ecosystem, providers offer specialized expertise and resources needed for an extensive evaluation. Anritsu Corporation, EXFO, Intertek Group Plc, and SGS SA are the key providers offering wireless testing services. These testing services employ advanced
Biopesticides Market Trends, Share, Comprehensive Analysis, Opportunity Assessment, Future Estimations and Key Industry Segments Poised for Strong Growth in Future to 2031
Biopesticides Market Trends, Share, Comprehensive Analysis, Opportunity Assessme …
The scope of the Advanced Biopesticides Market Report: The research report focuses on the current market trends, opportunities, future potential of the market, and competition in the Advanced Biopesticides in North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also provides market insights and analysis of the Advanced Biopesticides, highlighting the technological market trends, adoption rate, industry dynamics, and competitive analysis of major players in the
Animal Feed Additives Market: Industry Development Challenges, Opportunities, Entry Strategies, Key Manufacturers Analysis to 2031
Animal Feed Additives Market: Industry Development Challenges, Opportunities, En …
The Proposed Animal Feed Additives Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. Request Sample Pages of this research at -
Contract Research Organization - Top Companies Regional and Data Analysis
Contract Research Organization - Top Companies Regional and Data Analysis
A Contract Research Organization (CRO) is a company that provides outsourced research services to pharmaceutical, biotechnology, and medical device firms, helping them conduct clinical trials, preclinical studies, data analysis, and regulatory submissions. CROs reduce the cost, time, and complexity of developing new drugs or medical products by offering specialized expertise, advanced technology, and global research infrastructure. They ensure studies comply with international regulatory standards and high-quality practices, allowing sponsor companies

All 5 Releases


More Releases for Pharmacogenomics

Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market. Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period. Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776 The pharmacogenomics market is segmented on the basis of
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028. The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy. These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain
Pharmacogenomics Market Worth $13.16 billion by 2029
Meticulous Research®-a leading global market research company, published a research report titled, 'Pharmacogenomics Market by Technology (PCR, Sequencing, Spectrometry, Electrophoresis), Application (Cancer, Cardiology, Neurology, Infectious Diseases), End User (Hospitals, Diagnostic Laboratories, Research Institutes)-Global Forecast to 2029.' Download Free Research Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=5366 According to this latest publication from Meticulous Research®, the global pharmacogenomics market is projected to reach $13.16 billion by 2029, at a CAGR of 8.6% during the forecast period